Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein VI. Suppression of adoptively transferred disease and differential effects of oral vs. intravenous tolerization
- 31 July 1993
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 46 (1-2) , 73-82
- https://doi.org/10.1016/0165-5728(93)90235-q
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple SclerosisScience, 1993
- In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen.The Journal of Experimental Medicine, 1993
- Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain.The Journal of Experimental Medicine, 1992
- DOWN-REGULATION OF THE IMMUNE RESPONSE TO HISTOCOMPATIBILITY ANTIGENS AND PREVENTION OF SENSITIZATION BY SKIN ALLOGRAFTS BY ORALLY ADMINISTERED ALLOANTIGEN1Transplantation, 1992
- Antigen-driven bystander suppression after oral administration of antigens.The Journal of Experimental Medicine, 1991
- T Cell Receptor Peptide Therapy Triggers Autoregulation of Experimental EncephalomyelitisScience, 1991
- The Role of Digestive Enzymes in Orally Induced Immune ToleranceImmunological Investigations, 1989
- T cell tolerance by clonal elimination in the thymusCell, 1987
- The regulation of immune responses to dietary protein antigensImmunology Today, 1987
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981